Showing results (61-70 of 1,085) with videos related to
Sort By:
Pageof 109
Critical Care (London, England)|December 29, 2012
Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profilingBrendon P Scicluna, Tom van der PollThrombosis Research|January 15, 2015
The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsisMarcel Schouten, Cornelis van 't Veer, Nadia Poulussen, et al.Annals of Medicine|January 30, 2003
Animal and human models for sepsisMarc J Schultz, Tom van der PollLancet (London, England)|November 3, 2009
Pathogenesis, treatment, and prevention of pneumococcal pneumoniaTom van der Poll, Steven M OpalThorax|July 2, 2025
Biological drivers of the host response in sepsisW Joost Wiersinga, Tom van der PollArchivum Immunologiae Et Therapiae Experimentalis|July 9, 2002
Modulation of pulmonary innate immunity during bacterial infection: animal studiesMarcus J Schultz, Tom van der PollCurrent Infectious Disease Reports|September 21, 2007
Is the septic response good or bad?Willem Joost Wiersinga, Tom van der PollThrombosis and Haemostasis|September 9, 2011
Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumoniaMarcel Schouten, Cornelis van 't Veer, Joris J T H Roelofs, et al.Shock (Augusta, Ga.)|December 23, 2004
Endogenous interleukin-12 improves the early antimicrobial host response to murine Escherichia coli peritonitisSebastiaan Weijer, Sandrine Florquin, Tom van der PollLancet (London, England)|March 19, 2002
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressorsJanine Dörffler-Melly, Evert de Jonge, Anne-Corneliede Pont, et al.Pageof 109